Drug Patent Expirations for the Week of August 14, 2022
AFINITOR (everolimus) Novartis Patent: 8,778,962 Expiration: Aug 18, 2022 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence […]
AFINITOR (everolimus) Novartis Patent: 8,778,962 Expiration: Aug 18, 2022 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence […]
Annual Drug Patent Expirations for KINEVAC Kinevac is a drug marketed by Bracco and is included in one NDA. It is available from one supplier. […]
IXEMPRA KIT (ixabepilone) R-pharm us llc Patent: RE41393 Expiration: Aug 8, 2022 See More … For more information on how DrugPatentWatch can help with your […]
Annual Drug Patent Expirations for JULUCA Juluca is a drug marketed by Viiv Hlthcare and is included in one NDA. It is available from one […]
Annual Drug Patent Expirations for EDURANT Edurant is a drug marketed by Janssen Prods and is included in one NDA. It is available from one […]
Annual Drug Patent Expirations for ODEFSEY Odefsey is a drug marketed by Gilead Sciences Inc and is included in one NDA. It is available from […]
Annual Drug Patent Expirations for COMPLERA Complera is a drug marketed by Gilead Sciences Inc and is included in one NDA. It is available from […]
Annual Drug Patent Expirations for IXEMPRA+KIT Ixempra Kit is a drug marketed by R-pharm Us Llc and is included in one NDA. It is available […]
Annual Drug Patent Expirations for DUAKLIR+PRESSAIR Duaklir Pressair is a drug marketed by Covis and is included in one NDA. There are five patents protecting […]
Annual Drug Patent Expirations for TUDORZA+PRESSAIR Tudorza Pressair is a drug marketed by Covis and is included in one NDA. It is available from one […]
Annual Drug Patent Expirations for HYSINGLA+ER Hysingla Er is a drug marketed by Purdue Pharma Lp and is included in one NDA. It is available […]
Annual Drug Patent Expirations for NUCYNTA Nucynta is a drug marketed by Collegium Pharm Inc and is included in three NDAs. It is available from […]
Annual Drug Patent Expirations for NUCYNTA+ER Nucynta Er is a drug marketed by Collegium Pharm Inc and is included in one NDA. It is available […]
MACRILEN (macimorelin acetate) Novo Patent: 6,861,409 Expiration: Aug 1, 2022 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business […]
Annual Drug Patent Expirations for ADDYI Addyi is a drug marketed by Sprout Pharms and is included in one NDA. It is available from one […]
Annual Drug Patent Expirations for MACRILEN Macrilen is a drug marketed by Novo and is included in one NDA. It is available from two suppliers. […]
MACRILEN (macimorelin acetate) Novo Patent: 6,861,409 Expiration: Aug 1, 2022 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business […]
Annual Drug Patent Expirations for EVAMIST Evamist is a drug marketed by Padagis Us and is included in one NDA. It is available from one […]
Annual Drug Patent Expirations for BEYAZ Beyaz is a drug marketed by Bayer Hlthcare and is included in one NDA. It is available from two […]
Annual Drug Patent Expirations for ABILIFY Abilify is a drug marketed by Otsuka and Otsuka Pharm Co Ltd and is included in six NDAs. It […]
Annual Drug Patent Expirations for NUPLAZID Nuplazid is a drug marketed by Acadia Pharms Inc and is included in two NDAs. It is available from […]
Annual Drug Patent Expirations for ZETIA Zetia is a drug marketed by Organon and is included in one NDA. There are two patents protecting this […]
Annual Drug Patent Expirations for VELCADE Velcade is a drug marketed by Takeda Pharms Usa and is included in one NDA. It is available from […]
Annual Drug Patent Expirations for ADASUVE Adasuve is a drug marketed by Alexza Pharms and is included in one NDA. It is available from one […]
Annual Drug Patent Expirations for WINLEVI Winlevi is a drug marketed by Sun Pharm and is included in one NDA. It is available from one […]
Annual Drug Patent Expirations for IXEMPRA+KIT Ixempra Kit is a drug marketed by R-pharm Us Llc and is included in one NDA. It is available […]
Annual Drug Patent Expirations for SPIRIVA Spiriva is a drug marketed by Boehringer Ingelheim and is included in two NDAs. It is available from two […]
LEQVIO (inclisiran sodium) Novartis Patent: 10,590,418 Expiration: Jul 19, 2022 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business […]
Annual Drug Patent Expirations for ONPATTRO Onpattro is a drug marketed by Alnylam Pharms Inc and is included in one NDA. There are twenty-one patents […]
Annual Drug Patent Expirations for NEUPRO Neupro is a drug marketed by Ucb Inc and is included in one NDA. It is available from one […]
Annual Drug Patent Expirations for DORIBAX Doribax is a drug marketed by Shionogi Inc and is included in one NDA. There is one patent protecting […]
Annual Drug Patent Expirations for GIMOTI Gimoti is a drug marketed by Evoke Pharma Inc and is included in one NDA. There are two patents […]
Annual Drug Patent Expirations for IXEMPRA+KIT Ixempra Kit is a drug marketed by R-pharm Us Llc and is included in one NDA. It is available […]
XOPENEX (levalbuterol hydrochloride) Akorn Patent: 6,451,289 Expiration: Mar 21, 2021 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business […]
Annual Drug Patent Expirations for XOPENEX Xopenex is a drug marketed by Akorn and Sunovion and is included in two NDAs. It is available from […]
Annual Drug Patent Expirations for NEOPROFEN Neoprofen is a drug marketed by Recordati Rare and is included in one NDA. It is available from two […]
Annual Drug Patent Expirations for NEOPROFEN Neoprofen is a drug marketed by Recordati Rare and is included in one NDA. It is available from two […]
Annual Drug Patent Expirations for FORTAMET Fortamet is a drug marketed by Andrx Labs Llc and is included in one NDA. It is available from […]
Annual Drug Patent Expirations for FORTAMET Fortamet is a drug marketed by Andrx Labs Llc and is included in one NDA. It is available from […]
TWIRLA (ethinyl estradiol; levonorgestrel) Agile Patent: 7,045,145 Expiration: Mar 14, 2021 See More … For more information on how DrugPatentWatch can help with your pharmaceutical […]
Annual Drug Patent Expirations for TWIRLA Twirla is a drug marketed by Agile and is included in one NDA. There are eight patents protecting this […]
TWIRLA (ethinyl estradiol; levonorgestrel) Agile Patent: 7,384,650 Expiration: Mar 14, 2021 See More … For more information on how DrugPatentWatch can help with your pharmaceutical […]
Annual Drug Patent Expirations for BIKTARVY Biktarvy is a drug marketed by Gilead Sciences Inc and is included in one NDA. It is available from […]
Annual Drug Patent Expirations for SYMTUZA Symtuza is a drug marketed by Janssen Prods and is included in one NDA. It is available from one […]
Annual Drug Patent Expirations for ENJUVIA Enjuvia is a drug marketed by Aspen and is included in one NDA. There are two patents protecting this […]
Annual Drug Patent Expirations for ORIAHNN+%28COPACKAGED%29 Oriahnn (copackaged) is a drug marketed by Abbvie Inc and is included in one NDA. It is available from […]
Annual Drug Patent Expirations for ORILISSA Orilissa is a drug marketed by Abbvie Inc and is included in one NDA. It is available from one […]
Annual Drug Patent Expirations for NUPLAZID Nuplazid is a drug marketed by Acadia Pharms Inc and is included in two NDAs. It is available from […]
Annual Drug Patent Expirations for PHEXXI Phexxi is a drug marketed by Evofem Inc and is included in one NDA. It is available from one […]
ANDROGEL (testosterone) Abbvie Patent: 6,503,894 Expiration: Mar 2, 2021 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence […]
Annual Drug Patent Expirations for ANDROGEL Androgel is a drug marketed by Abbvie and is included in two NDAs. It is available from two suppliers. […]
Annual Drug Patent Expirations for ANDROGEL Androgel is a drug marketed by Abbvie and is included in two NDAs. It is available from two suppliers. […]
Annual Drug Patent Expirations for ZOLADEX Zoladex is a drug marketed by Tersera and is included in two NDAs. It is available from two suppliers. […]
Annual Drug Patent Expirations for COMPLERA Complera is a drug marketed by Gilead Sciences Inc and is included in one NDA. It is available from […]
Annual Drug Patent Expirations for EDURANT Edurant is a drug marketed by Janssen Prods and is included in one NDA. It is available from one […]
Annual Drug Patent Expirations for JULUCA Juluca is a drug marketed by Viiv Hlthcare and is included in one NDA. It is available from one […]
Annual Drug Patent Expirations for ODEFSEY Odefsey is a drug marketed by Gilead Sciences Inc and is included in one NDA. It is available from […]
Annual Drug Patent Expirations for ZYKADIA Zykadia is a drug marketed by Novartis and is included in two NDAs. It is available from one supplier. […]
Annual Drug Patent Expirations for CARDIZEM+LA Cardizem La is a drug marketed by Bausch and is included in one NDA. It is available from two […]
CARDIZEM LA (diltiazem hydrochloride) Bausch Patent: 6,923,984 Expiration: Feb 25, 2021 See More … For more information on how DrugPatentWatch can help with your pharmaceutical […]
Annual Drug Patent Expirations for BRIVIACT Briviact is a drug marketed by Ucb Inc and is included in three NDAs. It is available from one […]
Annual Drug Patent Expirations for CLARINEX-D+12+HOUR Clarinex-d 12 Hour is a drug marketed by Merck Sharp Dohme and is included in one NDA. It is […]
CLARINEX-D 12 HOUR (desloratadine; pseudoephedrine sulfate) Merck sharp dohme Patent: 6,709,676 Expiration: Feb 18, 2021 See More … For more information on how DrugPatentWatch can […]
Annual Drug Patent Expirations for ENJUVIA Enjuvia is a drug marketed by Aspen and is included in one NDA. There are two patents protecting this […]
Annual Drug Patent Expirations for CRIXIVAN Crixivan is a drug marketed by Merck Sharp Dohme and is included in one NDA. It is available from […]
ENJUVIA (estrogens, conjugated synthetic b) Aspen Patent: 6,855,703 Expiration: Feb 12, 2021 See More … For more information on how DrugPatentWatch can help with your […]
ENJUVIA (estrogens, conjugated synthetic b) Aspen Patent: 6,855,703 Expiration: Feb 12, 2021 See More … For more information on how DrugPatentWatch can help with your […]
Annual Drug Patent Expirations for CRESTOR Crestor is a drug marketed by IPR and is included in one NDA. It is available from four suppliers. […]
Annual Drug Patent Expirations for AURYXIA Auryxia is a drug marketed by Keryx Biopharms and is included in one NDA. It is available from one […]
Annual Drug Patent Expirations for FORTICAL Fortical is a drug marketed by Upsher Smith Labs and is included in one NDA. There are three patents […]
Annual Drug Patent Expirations for LATISSE Latisse is a drug marketed by Allergan and is included in one NDA. It is available from one supplier. […]
ORILISSA (elagolix sodium) Abbvie inc Patent: 7,462,625 Expiration: Jan 25, 2021 See More … For more information on how DrugPatentWatch can help with your pharmaceutical […]
Annual Drug Patent Expirations for BRIDION Bridion is a drug marketed by Organon Sub Merck and is included in one NDA. It is available from […]
Annual Drug Patent Expirations for ORILISSA Orilissa is a drug marketed by Abbvie Inc and is included in one NDA. It is available from one […]
Annual Drug Patent Expirations for ORIAHNN+%28COPACKAGED%29 Oriahnn (copackaged) is a drug marketed by Abbvie Inc and is included in one NDA. It is available from […]
Annual Drug Patent Expirations for HALAVEN Halaven is a drug marketed by Eisai Inc and is included in one NDA. It is available from two […]
Annual Drug Patent Expirations for HALAVEN Halaven is a drug marketed by Eisai Inc and is included in one NDA. It is available from two […]
CARNITOR (levocarnitine) Leadiant biosci inc Patent: 6,696,493 Expiration: Jan 18, 2021 See More … For more information on how DrugPatentWatch can help with your pharmaceutical […]
CARNITOR (levocarnitine) Leadiant biosci inc Patent: 6,696,493 Expiration: Jan 18, 2021 See More … For more information on how DrugPatentWatch can help with your pharmaceutical […]
Annual Drug Patent Expirations for CARNITOR Carnitor is a drug marketed by Leadiant Biosci Inc and is included in three NDAs. It is available from […]
Annual Drug Patent Expirations for CARNITOR Carnitor is a drug marketed by Leadiant Biosci Inc and is included in three NDAs. It is available from […]
ESMOLOL HYDROCHLORIDE DOUBLE STRENGTH IN PLASTIC CONTAINER (esmolol hydrochloride) Hq spclt pharma Patent: 6,528,540 Expiration: Jan 12, 2021 See More … For more information on […]
Annual Drug Patent Expirations for ESMOLOL+HYDROCHLORIDE+DOUBLE+STRENGTH+IN+PLASTIC+CONTAINER Esmolol Hydrochloride Double Strength In Plastic Container is a drug marketed by Hq Spclt Pharma and is included in […]
Annual Drug Patent Expirations for ESMOLOL+HYDROCHLORIDE+IN+PLASTIC+CONTAINER Esmolol Hydrochloride In Plastic Container is a drug marketed by Hq Spclt Pharma and is included in one NDA. […]
Annual Drug Patent Expirations for RUBRACA Rubraca is a drug marketed by Clovis Oncology Inc and is included in one NDA. It is available from […]
Annual Drug Patent Expirations for ADDERALL+20 Adderall 20 is a drug marketed by Teva Womens and is included in one NDA. There is one patent […]
Annual Drug Patent Expirations for ADDERALL+20 Adderall 20 is a drug marketed by Teva Womens and is included in one NDA. There is one patent […]
Annual Drug Patent Expirations for ADDERALL+30 Adderall 30 is a drug marketed by Teva Womens and is included in one NDA. There is one patent […]
Annual Drug Patent Expirations for ADDERALL+30 Adderall 30 is a drug marketed by Teva Womens and is included in one NDA. There is one patent […]
Annual Drug Patent Expirations for ADDERALL+5 Adderall 5 is a drug marketed by Teva Womens and is included in one NDA. There is one patent […]
Annual Drug Patent Expirations for ADDERALL+5 Adderall 5 is a drug marketed by Teva Womens and is included in one NDA. There is one patent […]
Annual Drug Patent Expirations for ADDERALL+7.5 Adderall 7.5 is a drug marketed by Teva Womens and is included in one NDA. There is one patent […]
Annual Drug Patent Expirations for ADDERALL+7.5 Adderall 7.5 is a drug marketed by Teva Womens and is included in one NDA. There is one patent […]
Annual Drug Patent Expirations for ADDERALL+10 Adderall 10 is a drug marketed by Teva Womens and is included in one NDA. There is one patent […]
Annual Drug Patent Expirations for ADDERALL+10 Adderall 10 is a drug marketed by Teva Womens and is included in one NDA. There is one patent […]
Annual Drug Patent Expirations for ADDERALL+12.5 Adderall 12.5 is a drug marketed by Teva Womens and is included in one NDA. There is one patent […]
Annual Drug Patent Expirations for ADDERALL+12.5 Adderall 12.5 is a drug marketed by Teva Womens and is included in one NDA. There is one patent […]
Annual Drug Patent Expirations for ADDERALL+15 Adderall 15 is a drug marketed by Teva Womens and is included in one NDA. There is one patent […]
Annual Drug Patent Expirations for ADDERALL+15 Adderall 15 is a drug marketed by Teva Womens and is included in one NDA. There is one patent […]
Annual Drug Patent Expirations for CLEVIPREX Cleviprex is a drug marketed by Chiesi and is included in one NDA. It is available from two suppliers. […]
CLEVIPREX (clevidipine) Chiesi Patent: 5,856,346 Expiration: Jan 5, 2021 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence […]
Annual Drug Patent Expirations for XYREM Xyrem is a drug marketed by Jazz Pharms and is included in one NDA. It is available from one […]
CLEVIPREX (clevidipine) Chiesi Patent: 5,856,346 Expiration: Jan 5, 2021 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence […]
Annual Drug Patent Expirations for XYREM Xyrem is a drug marketed by Jazz Pharms and is included in one NDA. It is available from one […]
SPRYCEL (dasatinib) Bristol myers squibb Patent: 6,596,746 Expiration: Dec 28, 2020 See More … For more information on how DrugPatentWatch can help with your pharmaceutical […]
Annual Drug Patent Expirations for SPRYCEL Sprycel is a drug marketed by Bristol Myers Squibb and is included in one NDA. It is available from […]
Annual Drug Patent Expirations for ALLEGRA-D+24+HOUR+ALLERGY+AND+CONGESTION Allegra-d 24 Hour Allergy And Congestion is a drug marketed by Sanofi Aventis Us and is included in one […]
ALLEGRA-D 24 HOUR ALLERGY AND CONGESTION (fexofenadine hydrochloride; pseudoephedrine hydrochloride) Sanofi aventis us Patent: 6,613,357 Expiration: Dec 25, 2020 See More … For more information […]
Annual Drug Patent Expirations for CLARINEX-D+12+HOUR Clarinex-d 12 Hour is a drug marketed by Merck Sharp Dohme and is included in one NDA. It is […]
Annual Drug Patent Expirations for DEXILANT Dexilant is a drug marketed by Takeda Pharms Usa and is included in two NDAs. It is available from […]
Annual Drug Patent Expirations for LUTRATE+DEPOT+KIT Lutrate Depot Kit is a drug marketed by Gp-pharm Sa and is included in one NDA. There is one […]
Annual Drug Patent Expirations for DEXILANT+SOLUTAB Dexilant Solutab is a drug marketed by Takeda Pharms Usa and is included in one NDA. There are eleven […]
DEXILANT (dexlansoprazole) Takeda pharms usa Patent: 6,462,058 Expiration: Dec 15, 2020 See More … For more information on how DrugPatentWatch can help with your pharmaceutical […]
Annual Drug Patent Expirations for NUPLAZID Nuplazid is a drug marketed by Acadia Pharms Inc and is included in two NDAs. It is available from […]
DEXILANT (dexlansoprazole) Takeda pharms usa Patent: 6,462,058 Expiration: Dec 15, 2020 See More … For more information on how DrugPatentWatch can help with your pharmaceutical […]
Annual Drug Patent Expirations for XARELTO Xarelto is a drug marketed by Janssen Pharms and is included in one NDA. It is available from three […]
Annual Drug Patent Expirations for SAPHRIS Saphris is a drug marketed by Allergan and is included in one NDA. It is available from two suppliers. […]
Annual Drug Patent Expirations for XELJANZ Xeljanz is a drug marketed by Pfizer and Pf Prism Cv and is included in three NDAs. It is […]
Annual Drug Patent Expirations for XELJANZ+XR Xeljanz Xr is a drug marketed by Pfizer and is included in one NDA. It is available from two […]
Annual Drug Patent Expirations for XELJANZ Xeljanz is a drug marketed by Pfizer and Pf Prism Cv and is included in three NDAs. It is […]
Annual Drug Patent Expirations for PREVEN+EMERGENCY+CONTRACEPTIVE+KIT Preven Emergency Contraceptive Kit is a drug marketed by Teva Branded Pharm and is included in one NDA. There […]
PREVEN EMERGENCY CONTRACEPTIVE KIT (ethinyl estradiol; levonorgestrel) Teva branded pharm Patent: 6,156,742 Expiration: Dec 5, 2020 See More … For more information on how DrugPatentWatch […]
Annual Drug Patent Expirations for ENTEREG Entereg is a drug marketed by Cubist Pharms and is included in one NDA. It is available from one […]
Annual Drug Patent Expirations for MONISTAT+1+COMBINATION+PACK Monistat 1 Combination Pack is a drug marketed by Medtech Products and is included in one NDA. It is […]
Annual Drug Patent Expirations for FORADIL Foradil is a drug marketed by Novartis and is included in two NDAs. There is one patent protecting this […]
Annual Drug Patent Expirations for NEUPRO Neupro is a drug marketed by Ucb Inc and is included in one NDA. It is available from one […]
RISPERDAL CONSTA (risperidone) Janssen pharms Patent: 6,667,061 Expiration: Nov 25, 2020 See More … For more information on how DrugPatentWatch can help with your pharmaceutical […]
Annual Drug Patent Expirations for RISPERDAL+CONSTA Risperdal Consta is a drug marketed by Janssen Pharms and is included in one NDA. It is available from […]
Annual Drug Patent Expirations for ORBACTIV Orbactiv is a drug marketed by Melinta Therap and is included in one NDA. It is available from two […]
Annual Drug Patent Expirations for TWIRLA Twirla is a drug marketed by Agile and is included in one NDA. There are eight patents protecting this […]
Annual Drug Patent Expirations for DULERA Dulera is a drug marketed by Merck Sharp Dohme and is included in one NDA. It is available from […]
DULERA (formoterol fumarate; mometasone furoate) Merck sharp dohme Patent: 7,566,705 Expiration: Nov 21, 2020 See More … For more information on how DrugPatentWatch can help […]
Annual Drug Patent Expirations for NEOPROFEN Neoprofen is a drug marketed by Recordati Rare and is included in one NDA. It is available from two […]
Annual Drug Patent Expirations for FENSOLVI+KIT Fensolvi Kit is a drug marketed by Tolmar and is included in one NDA. It is available from one […]
Annual Drug Patent Expirations for RADICAVA Radicava is a drug marketed by Mitsubishi Tanabe and is included in one NDA. It is available from one […]
Annual Drug Patent Expirations for ELIGARD+KIT Eligard Kit is a drug marketed by Tolmar Therap and is included in four NDAs. It is available from […]
Annual Drug Patent Expirations for CHLORAPREP+WITH+TINT Chloraprep With Tint is a drug marketed by Becton Dickinson Co and is included in one NDA. It is […]
Annual Drug Patent Expirations for VIEKIRA+XR Viekira Xr is a drug marketed by Abbvie Inc and is included in one NDA. There are twenty-one patents […]
Annual Drug Patent Expirations for VIEKIRA+PAK+%28COPACKAGED%29 Viekira Pak (copackaged) is a drug marketed by Abbvie Inc and is included in one NDA. It is available […]
Annual Drug Patent Expirations for CHANTIX Chantix is a drug marketed by Pf Prism Cv and is included in one NDA. It is available from […]
Annual Drug Patent Expirations for CHLORAPREP+ONE-STEP Chloraprep One-step is a drug marketed by Becton Dickinson Co and is included in two NDAs. It is available […]
DILAUDID-HP (hydromorphone hydrochloride) Fresenius kabi usa Patent: 6,589,960 Expiration: Nov 9, 2020 See More … For more information on how DrugPatentWatch can help with your […]
Annual Drug Patent Expirations for PALLADONE Palladone is a drug marketed by Purdue Pharma Lp and is included in one NDA. There is one patent […]
Annual Drug Patent Expirations for DILAUDID Dilaudid is a drug marketed by Fresenius Kabi Usa and Rhodes Pharms and is included in three NDAs. It […]
Annual Drug Patent Expirations for DILAUDID-HP Dilaudid-hp is a drug marketed by Fresenius Kabi Usa and is included in one NDA. It is available from […]
Annual Drug Patent Expirations for AXUMIN Axumin is a drug marketed by Blue Earth and is included in one NDA. It is available from one […]
Annual Drug Patent Expirations for DILAUDID Dilaudid is a drug marketed by Fresenius Kabi Usa and Rhodes Pharms and is included in three NDAs. It […]
DILAUDID-HP (hydromorphone hydrochloride) Fresenius kabi usa Patent: 6,589,960 Expiration: Nov 9, 2020 See More … For more information on how DrugPatentWatch can help with your […]
Annual Drug Patent Expirations for CYSVIEW+KIT Cysview Kit is a drug marketed by Photocure Asa and is included in one NDA. It is available from […]
Annual Drug Patent Expirations for SYMTUZA Symtuza is a drug marketed by Janssen Prods and is included in one NDA. It is available from one […]
Annual Drug Patent Expirations for BIKTARVY Biktarvy is a drug marketed by Gilead Sciences Inc and is included in one NDA. It is available from […]
Annual Drug Patent Expirations for CAMPTOSAR Camptosar is a drug marketed by Pfizer Inc and is included in one NDA. It is available from one […]
Annual Drug Patent Expirations for CRESEMBA Cresemba is a drug marketed by Astellas and is included in two NDAs. It is available from one supplier. […]
Annual Drug Patent Expirations for VEREGEN Veregen is a drug marketed by Fougera Pharms Inc and is included in one NDA. It is available from […]
Annual Drug Patent Expirations for HYSINGLA+ER Hysingla Er is a drug marketed by Purdue Pharma Lp and is included in one NDA. It is available […]
METADATE CD (methylphenidate hydrochloride) Lannett co inc Patent: 6,344,215 Expiration: Oct 27, 2020 See More … For more information on how DrugPatentWatch can help with […]
Annual Drug Patent Expirations for SPRYCEL Sprycel is a drug marketed by Bristol Myers Squibb and is included in one NDA. It is available from […]
Annual Drug Patent Expirations for CAMPTOSAR Camptosar is a drug marketed by Pfizer Inc and is included in one NDA. It is available from one […]
Annual Drug Patent Expirations for METADATE+CD Metadate Cd is a drug marketed by Lannett Co Inc and is included in one NDA. It is available […]
Annual Drug Patent Expirations for LONHALA+MAGNAIR+KIT Lonhala Magnair Kit is a drug marketed by Sunovion Resp and is included in one NDA. It is available […]
Annual Drug Patent Expirations for CIALIS Cialis is a drug marketed by Lilly and is included in one NDA. It is available from seven suppliers. […]
Annual Drug Patent Expirations for TYZEKA Tyzeka is a drug marketed by Novartis and is included in two NDAs. There are three patents protecting this […]
Annual Drug Patent Expirations for THALOMID Thalomid is a drug marketed by Celgene and is included in one NDA. It is available from one supplier. […]
Annual Drug Patent Expirations for POMALYST Pomalyst is a drug marketed by Celgene and is included in one NDA. It is available from one supplier. […]
Annual Drug Patent Expirations for REVLIMID Revlimid is a drug marketed by Celgene and is included in one NDA. It is available from one supplier. […]
AVANDIA (rosiglitazone maleate) Sb pharmco Patent: 7,358,366 Expiration: Oct 19, 2020 See More … For more information on how DrugPatentWatch can help with your pharmaceutical […]
Annual Drug Patent Expirations for OMNARIS Omnaris is a drug marketed by Covis Pharma Bv and is included in one NDA. It is available from […]
Annual Drug Patent Expirations for DURYSTA Durysta is a drug marketed by Allergan Inc and is included in one NDA. It is available from one […]
Annual Drug Patent Expirations for OMNARIS Omnaris is a drug marketed by Covis Pharma Bv and is included in one NDA. It is available from […]
Annual Drug Patent Expirations for OZURDEX Ozurdex is a drug marketed by Allergan and is included in one NDA. It is available from one supplier. […]
Annual Drug Patent Expirations for AVANDIA Avandia is a drug marketed by Sb Pharmco and is included in one NDA. It is available from one […]
Annual Drug Patent Expirations for AVANDARYL Avandaryl is a drug marketed by Sb Pharmco and is included in one NDA. There is one patent protecting […]
Annual Drug Patent Expirations for RENAGEL Renagel is a drug marketed by Genzyme and is included in two NDAs. It is available from two suppliers. […]
Annual Drug Patent Expirations for AMITIZA Amitiza is a drug marketed by Sucampo Pharma Llc and is included in one NDA. It is available from […]
Annual Drug Patent Expirations for GATTEX+KIT Gattex Kit is a drug marketed by Nps Pharms Inc and is included in one NDA. It is available […]
Annual Drug Patent Expirations for SPRYCEL Sprycel is a drug marketed by Bristol Myers Squibb and is included in one NDA. It is available from […]
VENTOLIN HFA (albuterol sulfate) Glaxosmithkline Patent: 9,861,771 Expiration: Oct 11, 2020 See More … For more information on how DrugPatentWatch can help with your pharmaceutical […]
Annual Drug Patent Expirations for LESCOL+XL Lescol Xl is a drug marketed by Novartis and is included in one NDA. It is available from two […]
Annual Drug Patent Expirations for MOXATAG Moxatag is a drug marketed by Pragma and is included in one NDA. There are six patents protecting this […]
Annual Drug Patent Expirations for PICATO Picato is a drug marketed by Leo Labs and is included in one NDA. It is available from one […]
BYDUREON PEN (exenatide synthetic) Astrazeneca ab Patent: 9,198,925 Expiration: Oct 4, 2020 See More … For more information on how DrugPatentWatch can help with your […]
Annual Drug Patent Expirations for XIGDUO+XR Xigduo Xr is a drug marketed by Astrazeneca Ab and is included in one NDA. It is available from […]
Annual Drug Patent Expirations for FARXIGA Farxiga is a drug marketed by Astrazeneca Ab and is included in one NDA. It is available from three […]
Annual Drug Patent Expirations for QTERN Qtern is a drug marketed by Astrazeneca Ab and is included in two NDAs. It is available from one […]
BYDUREON (exenatide synthetic) Astrazeneca ab Patent: 9,198,925 Expiration: Oct 4, 2020 See More … For more information on how DrugPatentWatch can help with your pharmaceutical […]
Annual Drug Patent Expirations for BYDUREON Bydureon is a drug marketed by Astrazeneca Ab and is included in two NDAs. It is available from one […]
Annual Drug Patent Expirations for BYDUREON+PEN Bydureon Pen is a drug marketed by Astrazeneca Ab and is included in one NDA. It is available from […]
Annual Drug Patent Expirations for BYDUREON+BCISE Bydureon Bcise is a drug marketed by Astrazeneca Ab and is included in one NDA. It is available from […]
Annual Drug Patent Expirations for QTERNMET+XR Qternmet Xr is a drug marketed by Astrazeneca Ab and is included in one NDA. It is available from […]
Annual Drug Patent Expirations for OFEV Ofev is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from one […]
Copyright © 2024 | WordPress Theme by MH Themes